The annual report of former AIM-traded company Meldex International plc for the December 2008 year end has been published and includes revealing statements from the new CEO about the serious lapses in corporate governance during the tenure of his predecessor.
In June 2009, Meldex, the Cambridge-based pharmaceutical company whose shares were suspended …… continue reading >>
Loading...